Oropharyngeal squamous cell carcinoma

1 paper1 finding

Humans1

Associations

1

HPV vaccine

downin humans1HR 0.087

1 study

HPV vaccine lowers the risk of oropharyngeal squamous cell carcinoma in humans (HR, 0.087).
Humans
HPV vaccination and risk of head and neck cancers: a large real-world cohort study
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases16 Aug 2026

More on HPV vaccine

Trial sponsors

University of Warwick
1 trialPhase 3334 people
National Cancer Institute
2 trialsPhase 2/3580 people
Shanghai Zhongshan Hospital
2 trialsPhase 2248 people
University of Florida
1 trialPhase 2250 people
Peking University Hospital of Stomatology
1 trialPhase 2110 people
Sara Medek
1 trialPhase 231 people
Institut Claudius Regaud
1 trialPhase 211 people
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
1 trialEarly phase 138 people

Latest

1 in 12 months

International Journal of Infectious Diseases16 Aug

HPV vaccination and risk of head and neck cancers: a large real-world cohort study

Cohort study in peopleInterventions